Letermovir

Kathryn Dzintars, Pharm.D., BCPS

INDICATIONS

FDA

  • Prophlyaxis of cytomegalovirus infection (CMV) in patients (> 18 years of age) who are CMV-seropositive and have undergone an allogeneic stem cell transplant

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: June 6, 2018